Minerva Neurosciences Stock Probability of Future Stock Price Finishing Over 2.11
| NERV Stock | USD 2.26 0.00 0.00% |
Minerva |
Minerva Neurosciences Target Price Odds to finish over 2.11
The tendency of Minerva Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above $ 2.11 in 90 days |
| 2.26 | 90 days | 2.11 | about 98.0 |
Based on a normal probability distribution, the odds of Minerva Neurosciences to stay above $ 2.11 in 90 days from now is about 98.0 (This Minerva Neurosciences probability density function shows the probability of Minerva Stock to fall within a particular range of prices over 90 days) . Probability of Minerva Neurosciences price to stay between $ 2.11 and its current price of $2.26 at the end of the 90-day period is about 7.1 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.02 . This indicates Minerva Neurosciences market returns are correlated to returns on the market. As the market goes up or down, Minerva Neurosciences is expected to follow. Additionally Minerva Neurosciences has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Minerva Neurosciences Price Density |
| Price |
Predictive Modules for Minerva Neurosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Minerva Neurosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Minerva Neurosciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Minerva Neurosciences is not an exception. The market had few large corrections towards the Minerva Neurosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Minerva Neurosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Minerva Neurosciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.47 | |
β | Beta against Dow Jones | 1.02 | |
σ | Overall volatility | 0.22 | |
Ir | Information ratio | -0.16 |
Minerva Neurosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Minerva Neurosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Minerva Neurosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Minerva Neurosciences generated a negative expected return over the last 90 days | |
| Minerva Neurosciences has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (30.01 M) with loss before overhead, payroll, taxes, and interest of (16.84 M). | |
| Minerva Neurosciences currently holds about 40.22 M in cash with (14.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.53, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Minerva Neurosciences has a frail financial position based on the latest SEC disclosures | |
| Roughly 22.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from thelincolnianonline.com: 2,790,698 Shares in ProMIS Neurosciences, Inc. Purchased by Great Point Partners LLC |
Minerva Neurosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Minerva Stock often depends not only on the future outlook of the current and potential Minerva Neurosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Minerva Neurosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 6.5 M | |
| Cash And Short Term Investments | 41 M |
Minerva Neurosciences Technical Analysis
Minerva Neurosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Minerva Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Minerva Neurosciences. In general, you should focus on analyzing Minerva Stock price patterns and their correlations with different microeconomic environments and drivers.
Minerva Neurosciences Predictive Forecast Models
Minerva Neurosciences' time-series forecasting models is one of many Minerva Neurosciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Minerva Neurosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Minerva Neurosciences
Checking the ongoing alerts about Minerva Neurosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Minerva Neurosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Minerva Neurosciences generated a negative expected return over the last 90 days | |
| Minerva Neurosciences has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (30.01 M) with loss before overhead, payroll, taxes, and interest of (16.84 M). | |
| Minerva Neurosciences currently holds about 40.22 M in cash with (14.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.53, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Minerva Neurosciences has a frail financial position based on the latest SEC disclosures | |
| Roughly 22.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from thelincolnianonline.com: 2,790,698 Shares in ProMIS Neurosciences, Inc. Purchased by Great Point Partners LLC |
Additional Tools for Minerva Stock Analysis
When running Minerva Neurosciences' price analysis, check to measure Minerva Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Minerva Neurosciences is operating at the current time. Most of Minerva Neurosciences' value examination focuses on studying past and present price action to predict the probability of Minerva Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Minerva Neurosciences' price. Additionally, you may evaluate how the addition of Minerva Neurosciences to your portfolios can decrease your overall portfolio volatility.